ACADIA Pharmaceuticals Inc. (LON:0A4W)
London
· Delayed Price · Currency is GBP · Price in USD 18.62
-0.02 (-0.11%)
At close: Jan 31, 2025
ACADIA Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 228.88 | 226.45 | -61.29 | -215.98 | -167.87 | -281.58 | Upgrade
|
| Depreciation & Amortization | 13.31 | 15.88 | 5.55 | 2.03 | 3.34 | 2.93 | Upgrade
|
| Loss (Gain) From Sale of Assets | -146.52 | -146.52 | - | - | - | 0.28 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 44.28 | Upgrade
|
| Loss (Gain) From Sale of Investments | -9.63 | -9.3 | -12.12 | -6.28 | 0.08 | 2.47 | Upgrade
|
| Stock-Based Compensation | 63.68 | 67.05 | 66.42 | 68.2 | 63.62 | 84.42 | Upgrade
|
| Change in Accounts Receivable | -11.04 | -0.47 | -36.07 | 2.17 | -16.12 | -12.47 | Upgrade
|
| Change in Inventory | -43.36 | -49.55 | -28.81 | 2.42 | -4.21 | -3.32 | Upgrade
|
| Change in Accounts Payable | -1.24 | -1.35 | 4.8 | 5.87 | -1.62 | 1.27 | Upgrade
|
| Change in Other Net Operating Assets | 54.88 | 55.53 | 78.22 | 27.54 | -2.88 | 25.55 | Upgrade
|
| Operating Cash Flow | 148.96 | 157.72 | 16.7 | -114.04 | -125.66 | -136.17 | Upgrade
|
| Operating Cash Flow Growth | 133.80% | 844.31% | - | - | - | - | Upgrade
|
| Capital Expenditures | -0.52 | -0.52 | -0.05 | - | -1.12 | -7.59 | Upgrade
|
| Sale of Property, Plant & Equipment | 146.52 | 146.52 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -98.84 | - | -40 | - | - | - | Upgrade
|
| Investment in Securities | -187.7 | -176.53 | 72.05 | 73.24 | -69.98 | 200.1 | Upgrade
|
| Investing Cash Flow | -140.55 | -30.54 | 32 | 73.24 | -71.1 | 192.51 | Upgrade
|
| Issuance of Common Stock | 7.64 | 6.85 | 25.13 | 8.2 | 18.16 | 81 | Upgrade
|
| Financing Cash Flow | 7.64 | 6.85 | 25.13 | 8.2 | 18.16 | 81 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.1 | -0.09 | -0.02 | 0.01 | 0.01 | -0.01 | Upgrade
|
| Net Cash Flow | 15.95 | 133.93 | 73.81 | -32.59 | -178.59 | 137.33 | Upgrade
|
| Free Cash Flow | 148.44 | 157.2 | 16.65 | -114.04 | -126.78 | -143.75 | Upgrade
|
| Free Cash Flow Growth | 133.16% | 844.01% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 14.90% | 16.41% | 2.29% | -22.05% | -26.19% | -32.54% | Upgrade
|
| Free Cash Flow Per Share | 0.89 | 0.94 | 0.10 | -0.70 | -0.79 | -0.91 | Upgrade
|
| Cash Income Tax Paid | 19.52 | 19.52 | 5.85 | 2.19 | 1.04 | 1.11 | Upgrade
|
| Levered Free Cash Flow | 19.27 | 270.08 | 28.44 | -34.96 | -65.26 | -59.7 | Upgrade
|
| Unlevered Free Cash Flow | 19.27 | 270.08 | 28.44 | -34.96 | -65.26 | -59.7 | Upgrade
|
| Change in Net Working Capital | 13.58 | -135 | -42.38 | -34.56 | 24.58 | -6.65 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.